Essilor International, the French ophthalmic optics company that designs, manufactures and distributes lenses, was fined by the French Competition Authority (FCA). The company will have to shell out €81 million to settle the penalty with the antitrust regulators in France.
According to Reuters, the FCA handed down its decision to Essilor for alleged unfair business practices. The competition watchdog said that the fine was for the violations that stretch over 11 years.
The authorities explained this week that optic lens maker’s actions had been mapped out to impede the development of online sales for corrective lenses in France. EssilorLuxottica, Essilor’s parent company, will pay €15 million out of the total penalty of €81 million.
The Autorite de la Concurrence said EssilorLuxottica and its Essilor International engaged in practices that blocked online sales of some prescription lenses in the country. The antitrust regulator determined that Essilor abused its dominant position in the lenses distribution market this move has become an obstruction in the growth of online sales of other eye-corrective lens and eyeglasses firms such as DirectOptic, Sensee, and Happyview.
Market Watch reported that as early as 2009, Essilor prevented some online platforms from selling its Essilor or Varilux optic lenses to customers. The authorities added the company refused to deliver its branded lenses as well while also barring the websites from displaying the Essilor logo and trademark. This practice continued for more than a decade, which is why the FCA imposed a hefty fine.
Meanwhile, in a press release, EssilorLuxottica said it is challenging the decision of the FCA. The revealed its intention to file an appeal as it strongly disagrees with the regulators’ decision.
“EssilorLuxottica acknowledges that the French competition authority (FCA) has published today a decision concerning Essilor International,” the French-Italian Ray-Ban manufacturer said. “EssilorLuxottica firmly believes in the legality of its practices and in the relevancy of distributing specific segments of prescription products under conditions that enable us to ensure that consumers can get the best vision correction that is required by their individual vision needs.”
EssilorLuxottica further reiterated that its business practices were fully compliant with the competitive and regulatory conditions in the mentioned period. For its appeal, the firm is confident that it will be able to prove that the FCA’s decision is groundless.


Bank of Japan Warns of Regional Economic Risks Amid Middle East Conflict and Rising Oil Prices
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
India's Services Sector Growth Slows to 14-Month Low in March Amid Rising Costs
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
March 2025 Jobs Report: Strong Headline Numbers Hide Deeper Economic Concerns
Morgan Stanley: Fed Rate Cuts Still on Track Despite Oil-Driven Inflation
Asian Markets Rally on Iran Ceasefire Hopes as US-Iran Tensions Simmer
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Energy Prices and Dollar Climb as U.S.-Iran Conflict Grips Global Markets
U.S. Job Market Braces for Slow Recovery Amid Middle East Tensions and Economic Uncertainty
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Britain Courts Anthropic Amid US Defense Department Dispute
Gold Prices Slip in Asia as Iran Strait Deadline Looms
U.S. Warplane Shot Down by Iran Amid Escalating Middle East Conflict
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
US Dollar Dips as Iran Rejects Ceasefire Amid Rising Middle East Tensions 



